Biocartis Group N.V.
BIOGF · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $30 | $31 | $57,450 | $24,135 |
| % Growth | -5.1% | -99.9% | 138% | – |
| Cost of Goods Sold | $31 | $34 | $29,765 | $16,961 |
| Gross Profit | -$2 | -$3 | $27,685 | $7,174 |
| % Margin | -6.3% | -9.1% | 48.2% | 29.7% |
| R&D Expenses | $18 | $19 | $38,374 | $24,027 |
| G&A Expenses | $8 | $8 | $3,516 | $1,661 |
| SG&A Expenses | $19 | $18 | $8,555 | $3,202 |
| Sales & Mktg Exp. | $11 | $11 | $5,038 | $1,541 |
| Other Operating Expenses | -$18 | $0 | $27,467 | $0 |
| Operating Expenses | $19 | $27 | $74,406 | $38,323 |
| Operating Income | -$21 | -$21 | -$47,026 | -$31,323 |
| % Margin | -70.1% | -68.1% | -81.9% | -129.8% |
| Other Income/Exp. Net | -$11 | -$16 | -$18,558 | -$4,535 |
| Pre-Tax Income | -$31 | -$37 | -$65,584 | -$35,858 |
| Tax Expense | -$0 | -$0 | -$240 | -$122 |
| Net Income | -$31 | -$37 | -$65,344 | -$35,736 |
| % Margin | -105.5% | -117.3% | -113.7% | -148.1% |
| EPS | -0.34 | -0.58 | -0.5 | -0.62 |
| % Growth | 41.4% | -16% | 19.4% | – |
| EPS Diluted | -0.34 | -0.58 | -0.5 | -0.62 |
| Weighted Avg Shares Out | 93 | 64 | 64 | 57,545 |
| Weighted Avg Shares Out Dil | 93 | 64 | 64 | 57,546 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $6 | $0 | $539 |
| Interest Expense | $0 | $0 | $11,187 | $4,660 |
| Depreciation & Amortization | $5 | $5 | $10,476 | $4,923 |
| EBITDA | -$16 | -$16 | -$43,937 | -$26,275 |
| % Margin | -52.6% | -51.4% | -76.5% | -108.9% |